首页 > 最新文献

iLABMED最新文献

英文 中文
Rapid diagnosis of Mycoplasma pneumoniae and prediction of antibiotic resistance by nanopore adaptive sampling 应用纳米孔自适应取样快速诊断肺炎支原体及预测抗生素耐药性
Pub Date : 2024-11-11 DOI: 10.1002/ila2.64
Yunke Sun, Xiaonan Li, Jiale He, Lingguo Zhao, Qingliang Chen, Lei Lei, Jun Chen, Lin Zhong, Guobao Li, Yu Xia, Yanmin Bao, Yingdan Zhang, Liang Yang
<div> <section> <h3> Background</h3> <p>Microbial infections, particularly in children, require rapid and accurate diagnostics. It is difficult to differentiate pathogens from commensal organisms, and it is impossible to identify antibiotic resistance genes that belong to pathogens with current methods. Third-generation sequencing provides rapid library preparation and real-time data acquisition. Nanopore normal sampling (NNS) enables unbiased sequencing of clinical samples without amplification, aiding pathogen identification and antimicrobial resistance gene prediction. However, clinical samples often contain a considerable amount of human DNA, potentially masking pathogen data. Nanopore adaptive sampling (NAS) aims to selectively enrich pathogens, promising improved diagnostics for acute infections and better treatment decisions in clinical practice. This study aimed to determine the utility of NAS in enhancing the real-time detection of pathogens and predicting AMR in infectious disease outbreaks.</p> </section> <section> <h3> Methods</h3> <p>This study used NAS technology to rapidly and directly detect <i>Mycoplasma pneumoniae</i> infection in bronchoalveolar lavage fluid samples from 28 pediatric patients at Shenzhen Children's Hospital. We assessed the efficacy of NAS compared with that of NNS by evaluating the number of microbial reads and the amount of microbial DNA data. We then compared the accuracy of detecting pathogens between NNS and NAS and between NAS and real-time polymerase chain reaction assays. Furthermore, we predicted antimicrobial resistance (AMR) and examined AMR genes associated with pathogens.</p> </section> <section> <h3> Results</h3> <p>NAS showed up to a 14.67-fold increase in the amount of microbial DNA data from patients' samples compared with NNS within the initial 2.5 h of sequencing. Additionally, NAS reduced the amount of host DNA data by up to 6.67-fold compared with NNS. Unlike TaqMan real-time polymerase chain reaction assays, NAS technology identified dominant pathogens and provided detailed insight into the abundance of the microbial community. Furthermore, NAS was able to predict AMR profiles of microbial communities and attribute specific AMR traits to individual microbes within the samples.</p> </section> <section> <h3> Conclusion</h3> <p>This study shows that NAS advances the clinical diagnosis because it can rapidly detect pathogens directly from patients' samples and provides antimicrobial resistance information for clinical guidance. These abilities further facilitate the application of NAS in persona
微生物感染,特别是儿童感染,需要快速和准确的诊断。很难区分病原体和共生生物,用目前的方法也不可能鉴定出属于病原体的抗生素耐药基因。第三代测序提供快速文库准备和实时数据采集。纳米孔正常采样(NNS)可以在不扩增的情况下对临床样品进行无偏测序,有助于病原体鉴定和抗微生物药物耐药性基因预测。然而,临床样本通常含有相当数量的人类DNA,可能掩盖病原体数据。纳米孔适应性采样(NAS)旨在选择性地丰富病原体,有望在临床实践中改进急性感染的诊断和更好的治疗决策。本研究旨在确定NAS在传染病暴发中增强病原体实时检测和预测抗菌素耐药性方面的应用。方法采用NAS技术快速、直接检测深圳市儿童医院28例患儿支气管肺泡灌洗液中肺炎支原体感染情况。我们通过评估微生物读取数和微生物DNA数据量来评估NAS与NNS的效果。然后,我们比较了NNS和NAS以及NAS和实时聚合酶链反应检测方法检测病原体的准确性。此外,我们预测了抗菌素耐药性(AMR),并检测了与病原体相关的AMR基因。结果在测序的最初2.5小时内,NAS显示来自患者样本的微生物DNA数据量比NNS增加了14.67倍。此外,与NNS相比,NAS将宿主DNA数据量减少了6.67倍。与TaqMan实时聚合酶链反应分析不同,NAS技术鉴定了优势病原体,并提供了微生物群落丰度的详细信息。此外,NAS能够预测微生物群落的AMR特征,并将特定的AMR特征归因于样品中的单个微生物。结论NAS可直接从患者样本中快速检测出病原菌,为临床指导提供耐药信息,促进了临床诊断的发展。这些能力进一步促进了NAS在个性化治疗中的应用,减少了广谱抗生素的误用,促进了患者的康复。
{"title":"Rapid diagnosis of Mycoplasma pneumoniae and prediction of antibiotic resistance by nanopore adaptive sampling","authors":"Yunke Sun,&nbsp;Xiaonan Li,&nbsp;Jiale He,&nbsp;Lingguo Zhao,&nbsp;Qingliang Chen,&nbsp;Lei Lei,&nbsp;Jun Chen,&nbsp;Lin Zhong,&nbsp;Guobao Li,&nbsp;Yu Xia,&nbsp;Yanmin Bao,&nbsp;Yingdan Zhang,&nbsp;Liang Yang","doi":"10.1002/ila2.64","DOIUrl":"https://doi.org/10.1002/ila2.64","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Background&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Microbial infections, particularly in children, require rapid and accurate diagnostics. It is difficult to differentiate pathogens from commensal organisms, and it is impossible to identify antibiotic resistance genes that belong to pathogens with current methods. Third-generation sequencing provides rapid library preparation and real-time data acquisition. Nanopore normal sampling (NNS) enables unbiased sequencing of clinical samples without amplification, aiding pathogen identification and antimicrobial resistance gene prediction. However, clinical samples often contain a considerable amount of human DNA, potentially masking pathogen data. Nanopore adaptive sampling (NAS) aims to selectively enrich pathogens, promising improved diagnostics for acute infections and better treatment decisions in clinical practice. This study aimed to determine the utility of NAS in enhancing the real-time detection of pathogens and predicting AMR in infectious disease outbreaks.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Methods&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;This study used NAS technology to rapidly and directly detect &lt;i&gt;Mycoplasma pneumoniae&lt;/i&gt; infection in bronchoalveolar lavage fluid samples from 28 pediatric patients at Shenzhen Children's Hospital. We assessed the efficacy of NAS compared with that of NNS by evaluating the number of microbial reads and the amount of microbial DNA data. We then compared the accuracy of detecting pathogens between NNS and NAS and between NAS and real-time polymerase chain reaction assays. Furthermore, we predicted antimicrobial resistance (AMR) and examined AMR genes associated with pathogens.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;NAS showed up to a 14.67-fold increase in the amount of microbial DNA data from patients' samples compared with NNS within the initial 2.5 h of sequencing. Additionally, NAS reduced the amount of host DNA data by up to 6.67-fold compared with NNS. Unlike TaqMan real-time polymerase chain reaction assays, NAS technology identified dominant pathogens and provided detailed insight into the abundance of the microbial community. Furthermore, NAS was able to predict AMR profiles of microbial communities and attribute specific AMR traits to individual microbes within the samples.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusion&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;This study shows that NAS advances the clinical diagnosis because it can rapidly detect pathogens directly from patients' samples and provides antimicrobial resistance information for clinical guidance. These abilities further facilitate the application of NAS in persona","PeriodicalId":100656,"journal":{"name":"iLABMED","volume":"2 4","pages":"266-276"},"PeriodicalIF":0.0,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ila2.64","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143252365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psychrobacter sanguinis infection in a pediatric patient with craniopharyngioma identified in a blood culture by 16S rRNA sequencing 通过16S rRNA测序在血培养中鉴定出儿童颅咽管瘤患者的血源性冻干杆菌感染
Pub Date : 2024-11-05 DOI: 10.1002/ila2.63
Jia Liu, Xueping Cao, Xiaoli Yang, Lijie Song, Feifei Duan, Wei Zhang, Yufei Wang

Psychrobacter species are gram-negative bacteria in the Moraxellaceae family. These bacteria are considered rare opportunistic human pathogens, and the infection sites include blood, cerebral spinal fluid, wounds, urine, the ears, and the eyes. Few cases of human infection by these species have been described previously. We report a case of a 10-year-old boy with postneurosurgical bacteremia due to Psychrobacter sanguinis infection. This infection was difficult to identify using routine biochemical phenotypical tests. Sequencing of 16S rRNA was performed to identify this pathogen. The patient was successfully treated with antibiotics. In conclusion, P. sanguinis infections are rare but should be considered when cultures remain negative for common pathogens.

冻干杆菌属革兰氏阴性菌属莫拉菌科。这些细菌被认为是罕见的机会性人类病原体,感染部位包括血液、脑脊液、伤口、尿液、耳朵和眼睛。以前很少有人被这些物种感染。我们报告一例10岁的男孩与神经手术后菌血症由于血冷杆菌感染。这种感染很难用常规生化表型试验来识别。采用16S rRNA测序鉴定该病原菌。病人用抗生素成功地治疗了。总之,血源弓形虫感染是罕见的,但应考虑当培养保持阴性的常见病原体。
{"title":"Psychrobacter sanguinis infection in a pediatric patient with craniopharyngioma identified in a blood culture by 16S rRNA sequencing","authors":"Jia Liu,&nbsp;Xueping Cao,&nbsp;Xiaoli Yang,&nbsp;Lijie Song,&nbsp;Feifei Duan,&nbsp;Wei Zhang,&nbsp;Yufei Wang","doi":"10.1002/ila2.63","DOIUrl":"https://doi.org/10.1002/ila2.63","url":null,"abstract":"<p><i>Psychrobacter</i> species are gram-negative bacteria in the Moraxellaceae family. These bacteria are considered rare opportunistic human pathogens, and the infection sites include blood, cerebral spinal fluid, wounds, urine, the ears, and the eyes. Few cases of human infection by these species have been described previously. We report a case of a 10-year-old boy with postneurosurgical bacteremia due to <i>Psychrobacter sanguinis</i> infection. This infection was difficult to identify using routine biochemical phenotypical tests. Sequencing of 16S rRNA was performed to identify this pathogen. The patient was successfully treated with antibiotics. In conclusion, <i>P. sanguinis</i> infections are rare but should be considered when cultures remain negative for common pathogens.</p>","PeriodicalId":100656,"journal":{"name":"iLABMED","volume":"2 4","pages":"323-326"},"PeriodicalIF":0.0,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ila2.63","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143248676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of albumin and lactate dehydrogenase in comparison with cytokeratin 19 fragments and neuron-specific enolase as diagnostic biomarkers for non-small cell lung cancer 白蛋白和乳酸脱氢酶与细胞角蛋白19片段和神经元特异性烯醇化酶作为非小细胞肺癌诊断生物标志物的比较
Pub Date : 2024-10-16 DOI: 10.1002/ila2.62
Xiaodong Feng, Ning Yuan, Wei Xu, Yingying Ji, Xiaoyan Yu, Zhijun Zhang

Background

The diagnosis of non-small cell lung cancer (NSCLC) is a clinical issue that requires attention, and more practical and effective biomarkers need to be selected to assist in diagnosis. This study aimed to examine the diagnostic value of serum albumin (ALB), lactate dehydrogenase (LDH), cytokeratin 19 fragments (CYFRA21-1), and neuron-specific enolase (NSE) for NSCLC.

Methods

The clinical data of 1048 NSCLC patients and 1125 healthy subjects were extracted from electronic medical records. Receiver operating characteristic (ROC) curve analysis was performed to assess the diagnostic significance of ALB, LDH, CYFRA21-1, and NSE for NSCLC. The Cancer Genome Atlas (TCGA) data, which included mRNA profiles for ALB and LDH expression, were acquired from TCGA Program. Finally, interactive survival scatter plots and survival analyses for NSCLC patients were evaluated using the Human Protein Atlas and Kaplan–Meier Plotter.

Results

Significant differences were noted in the levels of ALB and LDH between NSCLC patients and healthy controls. The areas under the ROC curves (AUCs) for ALB and LDH were 0.754 (95% CI: 0.734–0.774) and 0.681 (95% CI: 0.658–0.704), respectively. Moreover, the combination of ALB and LDH raised the AUC to 0.804 (95% CI: 0.785–0.823), and the incorporation of CYFRA21-1 and NSE further increased the AUC to 0.903 (95% CI: 0.890–0.916). Notably, ALB and LDH might be related to the overall survival of NSCLC patients.

Conclusion

This study revealed that ALB and LDH in NSCLC patient serum could improve the diagnostic accuracy of conventional biomarkers for NSCLC.

非小细胞肺癌(non-small cell lung cancer, NSCLC)的诊断是临床需要关注的问题,需要选择更实用有效的生物标志物来辅助诊断。本研究旨在探讨血清白蛋白(ALB)、乳酸脱氢酶(LDH)、细胞角蛋白19片段(CYFRA21-1)和神经元特异性烯醇化酶(NSE)对非小细胞肺癌的诊断价值。方法从电子病历中提取1048例非小细胞肺癌患者和1125例健康人的临床资料。采用受试者工作特征(ROC)曲线分析,评价ALB、LDH、CYFRA21-1、NSE对NSCLC的诊断意义。癌症基因组图谱(TCGA)数据,包括ALB和LDH表达的mRNA谱,来自TCGA项目。最后,使用人类蛋白图谱和Kaplan-Meier绘图仪评估NSCLC患者的交互生存散点图和生存分析。结果非小细胞肺癌患者ALB和LDH水平与健康对照组有显著差异。ALB和LDH的ROC曲线下面积(auc)分别为0.754 (95% CI: 0.734 ~ 0.774)和0.681 (95% CI: 0.658 ~ 0.704)。ALB与LDH联合使AUC提高至0.804 (95% CI: 0.785-0.823), CYFRA21-1与NSE联合使AUC进一步提高至0.903 (95% CI: 0.890-0.916)。值得注意的是,ALB和LDH可能与NSCLC患者的总生存率有关。结论非小细胞肺癌患者血清中ALB和LDH可提高非小细胞肺癌常规生物标志物的诊断准确性。
{"title":"Evaluation of albumin and lactate dehydrogenase in comparison with cytokeratin 19 fragments and neuron-specific enolase as diagnostic biomarkers for non-small cell lung cancer","authors":"Xiaodong Feng,&nbsp;Ning Yuan,&nbsp;Wei Xu,&nbsp;Yingying Ji,&nbsp;Xiaoyan Yu,&nbsp;Zhijun Zhang","doi":"10.1002/ila2.62","DOIUrl":"https://doi.org/10.1002/ila2.62","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>The diagnosis of non-small cell lung cancer (NSCLC) is a clinical issue that requires attention, and more practical and effective biomarkers need to be selected to assist in diagnosis. This study aimed to examine the diagnostic value of serum albumin (ALB), lactate dehydrogenase (LDH), cytokeratin 19 fragments (CYFRA21-1), and neuron-specific enolase (NSE) for NSCLC.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The clinical data of 1048 NSCLC patients and 1125 healthy subjects were extracted from electronic medical records. Receiver operating characteristic (ROC) curve analysis was performed to assess the diagnostic significance of ALB, LDH, CYFRA21-1, and NSE for NSCLC. The Cancer Genome Atlas (TCGA) data, which included mRNA profiles for ALB and LDH expression, were acquired from TCGA Program. Finally, interactive survival scatter plots and survival analyses for NSCLC patients were evaluated using the Human Protein Atlas and Kaplan–Meier Plotter.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Significant differences were noted in the levels of ALB and LDH between NSCLC patients and healthy controls. The areas under the ROC curves (AUCs) for ALB and LDH were 0.754 (95% CI: 0.734–0.774) and 0.681 (95% CI: 0.658–0.704), respectively. Moreover, the combination of ALB and LDH raised the AUC to 0.804 (95% CI: 0.785–0.823), and the incorporation of CYFRA21-1 and NSE further increased the AUC to 0.903 (95% CI: 0.890–0.916). Notably, ALB and LDH might be related to the overall survival of NSCLC patients.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>This study revealed that ALB and LDH in NSCLC patient serum could improve the diagnostic accuracy of conventional biomarkers for NSCLC.</p>\u0000 </section>\u0000 </div>","PeriodicalId":100656,"journal":{"name":"iLABMED","volume":"2 4","pages":"227-237"},"PeriodicalIF":0.0,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ila2.62","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143252626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic value of exosomal N-glycan profiles for microvascular invasion in hepatocellular carcinoma 外泌体n -聚糖谱对肝细胞癌微血管浸润的诊断价值
Pub Date : 2024-10-14 DOI: 10.1002/ila2.61
Huijuan Feng, Junping Ke, Liping Zheng, Chenjun Huang, Lijuan Liu

Background

Microvascular invasion (MVI) was a critical high-risk factor for postoperative recurrence and adverse prognosis in patients with hepatocellular carcinoma (HCC), and there were no reliable non-invasive pre-operative diagnostic markers. The exosomal N-glycan profile was closely related to the invasion and immune escape of HCC. Therefore, this article investigated the expression of N-glycan profiles in serum exosomes of patients with HCC and its clinical significance for MVI.

Methods

Serum samples from 210 patients with HCC were collected and randomly divided into modeling and validation cohorts. The abundances of N-glycans in serum exosomes with different MVI grades were determined. A diagnostic model for MVI in HCC based on N-glycosylation was constructed and the diagnostic value was analyzed.

Results

In the modeling cohort, comparing groups M0 with M2, the area under the receiver operating characteristic (AUC) of the diagnostic model namely SUM (AUCSUM) was 0.861, the sensitivity of SUM was 92.68%, and the specificity of SUM was 79.41%, all of which were higher than the seven individual indexes (containing Peak 1, Peak 6, Peak 9, Peak 10, Peak 12, AFP, and PIVKA-II). In the comparison between the M1 and M2 groups, the AUCSUM was 0.749, the sensitivity of SUM was 79.07%, and the specificity of SUM was 76.60%, all of which were higher than the seven individual indexes. When comparing the M0 and M1 groups, the AUCSUM was 0.712, the sensitivity of SUM was 88.57%, and the specificity of SUM was 65.00%. The AUCSUM and sensitivity of SUM were higher than the seven individual indexes and the specificity of SUM was slightly lower than that of AFP (68.18%) but higher than other individual indexes. The results of the validation cohort were similar to those of the modeling cohort.

Conclusion

The SUM model of serum exosomes can serve as an auxiliary diagnostic index for MVI staging in patients with HCC.

背景:微血管侵犯(Microvascular invasion, MVI)是肝细胞癌(HCC)患者术后复发和预后不良的重要高危因素,目前尚无可靠的无创术前诊断指标。外泌体n -聚糖谱与HCC的侵袭和免疫逃逸密切相关。因此,本文研究了n -聚糖谱在HCC患者血清外泌体中的表达及其对MVI的临床意义。方法收集210例HCC患者血清样本,随机分为模型组和验证组。测定不同MVI等级血清外泌体中n -聚糖的丰度。建立基于n -糖基化的肝癌MVI诊断模型,并分析其诊断价值。结果在建模队列中,M0组与M2组比较,诊断模型即SUM (AUCSUM)的受者工作特征(AUC)下面积为0.861,SUM的敏感性为92.68%,SUM的特异性为79.41%,均高于7个单项指标(包括Peak 1、Peak 6、Peak 9、Peak 10、Peak 12、AFP、PIVKA-II)。M1组与M2组比较,AUCSUM为0.749,SUM的敏感性为79.07%,特异性为76.60%,均高于7个单项指标。M0组与M1组比较,AUCSUM为0.712,SUM的敏感性为88.57%,特异性为65.00%。SUM的特异性略低于AFP(68.18%),但高于其他单项指标。验证队列的结果与建模队列的结果相似。结论血清外泌体SUM模型可作为肝癌患者MVI分期的辅助诊断指标。
{"title":"Diagnostic value of exosomal N-glycan profiles for microvascular invasion in hepatocellular carcinoma","authors":"Huijuan Feng,&nbsp;Junping Ke,&nbsp;Liping Zheng,&nbsp;Chenjun Huang,&nbsp;Lijuan Liu","doi":"10.1002/ila2.61","DOIUrl":"https://doi.org/10.1002/ila2.61","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Microvascular invasion (MVI) was a critical high-risk factor for postoperative recurrence and adverse prognosis in patients with hepatocellular carcinoma (HCC), and there were no reliable non-invasive pre-operative diagnostic markers. The exosomal N-glycan profile was closely related to the invasion and immune escape of HCC. Therefore, this article investigated the expression of N-glycan profiles in serum exosomes of patients with HCC and its clinical significance for MVI.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Serum samples from 210 patients with HCC were collected and randomly divided into modeling and validation cohorts. The abundances of N-glycans in serum exosomes with different MVI grades were determined. A diagnostic model for MVI in HCC based on N-glycosylation was constructed and the diagnostic value was analyzed.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>In the modeling cohort, comparing groups M0 with M2, the area under the receiver operating characteristic (AUC) of the diagnostic model namely SUM (AUC<sub>SUM</sub>) was 0.861, the sensitivity of SUM was 92.68%, and the specificity of SUM was 79.41%, all of which were higher than the seven individual indexes (containing Peak 1, Peak 6, Peak 9, Peak 10, Peak 12, AFP, and PIVKA-II). In the comparison between the M1 and M2 groups, the AUC<sub>SUM</sub> was 0.749, the sensitivity of SUM was 79.07%, and the specificity of SUM was 76.60%, all of which were higher than the seven individual indexes. When comparing the M0 and M1 groups, the AUC<sub>SUM</sub> was 0.712, the sensitivity of SUM was 88.57%, and the specificity of SUM was 65.00%. The AUC<sub>SUM</sub> and sensitivity of SUM were higher than the seven individual indexes and the specificity of SUM was slightly lower than that of AFP (68.18%) but higher than other individual indexes. The results of the validation cohort were similar to those of the modeling cohort.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The SUM model of serum exosomes can serve as an auxiliary diagnostic index for MVI staging in patients with HCC.</p>\u0000 </section>\u0000 </div>","PeriodicalId":100656,"journal":{"name":"iLABMED","volume":"2 4","pages":"238-247"},"PeriodicalIF":0.0,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ila2.61","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143252616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Regulatory factors of ILC2 are therapeutic targets for lung inflammation ILC2 的调节因子是肺部炎症的治疗靶点
Pub Date : 2024-09-23 DOI: 10.1002/ila2.59
Lele Cui, Yajie Wang

Type 2 innate lymphoid cells (ILC2s) are an important class of innate immune cells that play a key role in regulating immune responses, maintaining tissue homeostasis, and participating in immune responses induced by inflammatory diseases. In lung inflammation, ILC2s drive the inflammatory response by secreting type 2 cytokines, and have a significant role in tissue repair and the maintenance of barrier function by secreting IL-9 and antimicrobial peptides. ILC2s activation and function are affected by various regulatory factors, including epithelial-derived alarmins such as IL-25, IL-33, and thymic stromal lymphopoietin, neurotransmitters, metabolites and hormones. These regulatory factors affect the development and activation of ILC2s through signaling pathways under different pathological conditions. An in-depth study of regulatory factors is expected to provide new targets and strategies for the treatment of lung inflammation.

2型先天性淋巴细胞(ILC2s)是一类重要的先天性免疫细胞,在调节免疫反应、维持组织稳态和参与炎症性疾病诱导的免疫反应方面发挥着关键作用。在肺部炎症中,ILC2s 通过分泌 2 型细胞因子驱动炎症反应,并通过分泌 IL-9 和抗菌肽在组织修复和维持屏障功能方面发挥重要作用。ILC2 的活化和功能受到各种调节因子的影响,包括上皮源性 alarmins(如 IL-25、IL-33 和胸腺基质淋巴细胞生成素)、神经递质、代谢物和激素。这些调节因子在不同病理条件下通过信号通路影响 ILC2 的发育和激活。对调节因子的深入研究有望为肺部炎症的治疗提供新的靶点和策略。
{"title":"Regulatory factors of ILC2 are therapeutic targets for lung inflammation","authors":"Lele Cui,&nbsp;Yajie Wang","doi":"10.1002/ila2.59","DOIUrl":"https://doi.org/10.1002/ila2.59","url":null,"abstract":"<p>Type 2 innate lymphoid cells (ILC2s) are an important class of innate immune cells that play a key role in regulating immune responses, maintaining tissue homeostasis, and participating in immune responses induced by inflammatory diseases. In lung inflammation, ILC2s drive the inflammatory response by secreting type 2 cytokines, and have a significant role in tissue repair and the maintenance of barrier function by secreting IL-9 and antimicrobial peptides. ILC2s activation and function are affected by various regulatory factors, including epithelial-derived alarmins such as IL-25, IL-33, and thymic stromal lymphopoietin, neurotransmitters, metabolites and hormones. These regulatory factors affect the development and activation of ILC2s through signaling pathways under different pathological conditions. An in-depth study of regulatory factors is expected to provide new targets and strategies for the treatment of lung inflammation.</p>","PeriodicalId":100656,"journal":{"name":"iLABMED","volume":"2 3","pages":"205-220"},"PeriodicalIF":0.0,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ila2.59","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142404898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Etiology, clinical features, and epidemiological analysis of diarrhea patients visiting a gastrointestinal clinic in a comprehensive hospital in Beijing, China, in 2023 2023 年北京某综合医院胃肠门诊腹泻患者的病因、临床特征和流行病学分析
Pub Date : 2024-09-19 DOI: 10.1002/ila2.60
Lihua Qi, Siwei Zhou, Dongmei Gu

Objective

To investigate the clinical features and epidemiology of diarrhea patients and analyze the current distribution of enteropathogens causing diarrhea in a comprehensive hospital in Beijing, China, in 2023.

Materials and Methods

From April to October 2023, we enrolled patients with diarrheal diseases who visited the gastrointestinal clinic in our hospital. The patients' demographic, epidemiological, and clinical features were obtained via a questionnaire. Stool samples were examined for 20 enteropathogens by multiplex polymerase chain reaction testing.

Results

We enrolled 260 patients; men and adults accounted for 55.77% and 95.77% of the patients, respectively. The median age was 37 years. Eighty-four enteropathogens, 72 bacteria and 12 viruses, were identified in 74 patients. Enteroaggregative Escherichia coli was the predominant agent. Patients with and without pathogens detected in stool samples showed no significant differences in age, sex, gastrointestinal symptoms, and stool characteristics. Possible food-related events were recorded in 57.31% of the patients. Leukocyte counts in patients with bacterial infections were higher than those of patients with viral infections and those with no detected pathogens (p < 0.05). Seasonality of bacterial distribution was observed (p < 0.05).

Conclusion

Bacteria were predominant pathogens among the diarrhea patients. The incidence of diarrhea was related to hot weather and foodborne illness. Bacterial diarrhea may cause systemic infection. The clinical symptoms of infectious diarrhea were usually non-specific and unrelated to the type of infection. Timely and comprehensive multi-pathogen surveillance might be helpful to detect suspected pathogens and promote epidemic prevention and control.

摘要] 目的 调查 2023 年中国北京某综合医院腹泻患者的临床特征和流行病学,并分析目前引起腹泻的肠道病原体的分布情况。 材料与方法 2023 年 4 月至 10 月,我们对在我院胃肠门诊就诊的腹泻患者进行了登记。通过问卷调查了解患者的人口统计学、流行病学和临床特征。通过多重聚合酶链反应测试对粪便样本中的 20 种肠道病原体进行检测。 结果 我们共招募了 260 名患者,其中男性和成人分别占 55.77% 和 95.77%。年龄中位数为 37 岁。在 74 名患者中发现了 84 种肠道病原体,包括 72 种细菌和 12 种病毒。肠道聚集性大肠杆菌是主要病原体。粪便样本中检测到病原体的患者和未检测到病原体的患者在年龄、性别、胃肠道症状和粪便特征方面没有明显差异。57.31%的患者可能与食物有关。细菌感染患者的白细胞计数高于病毒感染患者和未检出病原体的患者(p < 0.05)。细菌分布具有季节性(p <0.05)。 结论 细菌是腹泻患者的主要病原体。腹泻发病率与炎热天气和食源性疾病有关。细菌性腹泻可引起全身感染。感染性腹泻的临床症状通常没有特异性,与感染类型无关。及时和全面的多种病原体监测可能有助于发现可疑病原体,促进疫情防控。
{"title":"Etiology, clinical features, and epidemiological analysis of diarrhea patients visiting a gastrointestinal clinic in a comprehensive hospital in Beijing, China, in 2023","authors":"Lihua Qi,&nbsp;Siwei Zhou,&nbsp;Dongmei Gu","doi":"10.1002/ila2.60","DOIUrl":"https://doi.org/10.1002/ila2.60","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To investigate the clinical features and epidemiology of diarrhea patients and analyze the current distribution of enteropathogens causing diarrhea in a comprehensive hospital in Beijing, China, in 2023.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Materials and Methods</h3>\u0000 \u0000 <p>From April to October 2023, we enrolled patients with diarrheal diseases who visited the gastrointestinal <span>c</span>linic in our hospital. The patients' demographic, epidemiological, and clinical features were obtained via a questionnaire. Stool samples were examined for 20 enteropathogens by multiplex polymerase chain reaction testing.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>We enrolled 260 patients; men and adults accounted for 55.77% and 95.77% of the patients, respectively. The median age was 37 years. Eighty-four enteropathogens, 72 bacteria and 12 viruses, were identified in 74 patients. Enteroaggregative <i>Escherichia coli</i> was the predominant agent. Patients with and without pathogens detected in stool samples showed no significant differences in age, sex, gastrointestinal symptoms, and stool characteristics. Possible food-related events were recorded in 57.31% of the patients. Leukocyte counts in patients with bacterial infections were higher than those of patients with viral infections and those with no detected pathogens (<i>p</i> &lt; 0.05). Seasonality of bacterial distribution was observed (<i>p</i> &lt; 0.05).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Bacteria were predominant pathogens among the diarrhea patients. The incidence of diarrhea was related to hot weather and foodborne illness. Bacterial diarrhea may cause systemic infection. The clinical symptoms of infectious diarrhea were usually non-specific and unrelated to the type of infection. Timely and comprehensive multi-pathogen surveillance might be helpful to detect suspected pathogens and promote epidemic prevention and control.</p>\u0000 </section>\u0000 </div>","PeriodicalId":100656,"journal":{"name":"iLABMED","volume":"2 3","pages":"197-204"},"PeriodicalIF":0.0,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ila2.60","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142404541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A retrospective analysis of the relationship between dermatomyositis-associated interstitial lung disease and disease duration, age, arterial blood gas pH, and serum Cl− levels 皮肌炎相关间质性肺病与病程、年龄、动脉血气pH值和血清Cl-水平之间关系的回顾性分析
Pub Date : 2024-09-12 DOI: 10.1002/ila2.56
Xu Zhang, Xuemei Wei, Xiaojuan Luan, Xiujuan Li, Jin Dong, Jingzhu Nan, Yanhong Gao

Background

Dermatomyositis-associated interstitial lung disease (DM-ILD) represents a severe and insidious complication of dermatomyositis (DM). The study aimed to investigate the association between DM-ILD and arterial blood gas indices, serum ion levels, and the timing of interstitial lung disease onset, with the goal of identifying potential predictors for DM-ILD.

Methods

The investigation involved the collection of basic data from 89 patients with DM hospitalized at the Chinese PLA General Hospital between January 2019 and April 2022, and 43 normal control patients hospitalized for physical examinations during the same period. Analyses were conducted to explore the relationship between DM-ILD, arterial blood gas indices, disease duration, and serum ions. A regression model to predict DM-ILD was developed using these indices, and a receiver operating characteristic curve was generated.

Results

Significant differences were observed in pH and PaO2 between the control group and the disease group (p < 0.05). The DM group exhibited higher levels of pH, actual bicarbonate, and base excess (BE) compared with the control group. In contrast, pH and BE levels were lower in the DM-ILD group than in the DM group, with these differences being statistically significant (p < 0.05). Interstitial lung disease was correlated with the duration of the disease and pH levels (p < 0.05). The cutoff values for age, disease duration, pH, and Cl were 55.5 years, 5.5 years, 7.432, and 101.5 mmol/L, respectively. The model demonstrated a prediction sensitivity and specificity for DM-ILD of 0.809 and 0.722, respectively, with an area under the curve of 0.809.

Conclusion

Arterial blood gas analysis and serum Cl levels may assist in predicting DM-ILD. A combined monitoring approach involving arterial blood gas pH, disease duration, age, and serum Cl levels could enhance the accuracy of DM-ILD predictions and hold significant clinical evaluation potential.

背景皮肌炎相关间质性肺病(DM-ILD)是皮肌炎(DM)的一种严重而隐匿的并发症。该研究旨在调查 DM-ILD 与动脉血气指数、血清离子水平和间质性肺病发病时间之间的关联,从而找出 DM-ILD 的潜在预测因素。 方法 收集2019年1月至2022年4月期间在中国人民解放军总医院住院治疗的89例DM患者和同期住院体检的43例正常对照组患者的基本资料。分析探讨了DM-ILD、动脉血气指数、病程和血清离子之间的关系。利用这些指标建立了预测 DM-ILD 的回归模型,并生成了接收者操作特征曲线。 结果 对照组和疾病组的 pH 和 PaO2 存在显著差异(p < 0.05)。与对照组相比,DM 组的 pH、实际碳酸氢盐和碱过量(BE)水平更高。相比之下,DM-ILD 组的 pH 和 BE 水平低于 DM 组,这些差异具有统计学意义(p < 0.05)。间质性肺病与病程和 pH 值相关(p < 0.05)。年龄、病程、pH 值和 Cl- 的临界值分别为 55.5 岁、5.5 岁、7.432 和 101.5 mmol/L。该模型对 DM-ILD 的预测灵敏度和特异度分别为 0.809 和 0.722,曲线下面积为 0.809。 结论 动脉血气分析和血清 Cl- 水平有助于预测 DM-ILD。包括动脉血气 pH 值、病程、年龄和血清 Cl- 水平在内的联合监测方法可提高 DM-ILD 预测的准确性,并具有重要的临床评估潜力。
{"title":"A retrospective analysis of the relationship between dermatomyositis-associated interstitial lung disease and disease duration, age, arterial blood gas pH, and serum Cl− levels","authors":"Xu Zhang,&nbsp;Xuemei Wei,&nbsp;Xiaojuan Luan,&nbsp;Xiujuan Li,&nbsp;Jin Dong,&nbsp;Jingzhu Nan,&nbsp;Yanhong Gao","doi":"10.1002/ila2.56","DOIUrl":"https://doi.org/10.1002/ila2.56","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Dermatomyositis-associated interstitial lung disease (DM-ILD) represents a severe and insidious complication of dermatomyositis (DM). The study aimed to investigate the association between DM-ILD and arterial blood gas indices, serum ion levels, and the timing of interstitial lung disease onset, with the goal of identifying potential predictors for DM-ILD.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The investigation involved the collection of basic data from 89 patients with DM hospitalized at the Chinese PLA General Hospital between January 2019 and April 2022, and 43 normal control patients hospitalized for physical examinations during the same period. Analyses were conducted to explore the relationship between DM-ILD, arterial blood gas indices, disease duration, and serum ions. A regression model to predict DM-ILD was developed using these indices, and a receiver operating characteristic curve was generated.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Significant differences were observed in pH and PaO<sub>2</sub> between the control group and the disease group (<i>p</i> &lt; 0.05). The DM group exhibited higher levels of pH, actual bicarbonate, and base excess (BE) compared with the control group. In contrast, pH and BE levels were lower in the DM-ILD group than in the DM group, with these differences being statistically significant (<i>p</i> &lt; 0.05). Interstitial lung disease was correlated with the duration of the disease and pH levels (<i>p</i> &lt; 0.05). The cutoff values for age, disease duration, pH, and Cl<sup>−</sup> were 55.5 years, 5.5 years, 7.432, and 101.5 mmol/L, respectively. The model demonstrated a prediction sensitivity and specificity for DM-ILD of 0.809 and 0.722, respectively, with an area under the curve of 0.809.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Arterial blood gas analysis and serum Cl<sup>−</sup> levels may assist in predicting DM-ILD. A combined monitoring approach involving arterial blood gas pH, disease duration, age, and serum Cl<sup>−</sup> levels could enhance the accuracy of DM-ILD predictions and hold significant clinical evaluation potential.</p>\u0000 </section>\u0000 </div>","PeriodicalId":100656,"journal":{"name":"iLABMED","volume":"2 3","pages":"168-177"},"PeriodicalIF":0.0,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ila2.56","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142404653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ginkgo biloba active compounds can modulate the development of acute mountain sickness and ischemic stroke as discovered by network pharmacology and molecular docking 通过网络药理学和分子对接发现的银杏叶活性化合物可调节急性山地病和缺血性中风的发生发展
Pub Date : 2024-09-03 DOI: 10.1002/ila2.58
Haoran Guo, Xueran Kang, Ying Xu, Chengbin Wang, Chi Wang

Background

A combination of molecular docking, molecular dynamics simulations, and herbal network pharmacology was used to investigate the shared key targets and potential mechanisms underlying the preventive effects of Ginkgo biloba active compounds against acute mountain sickness (AMS) and ischemic stroke (IS).

Material and Methods

The Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform was used to screen the main active compounds of Ginkgo biloba and their corresponding targets. We obtained AMS-related genes by mining several databases and cross-correlated them with key active compounds of Ginkgo biloba to identify relevant action targets for treating AMS. The STRING database was used to construct a protein–protein interaction network of the effect of Ginkgo biloba active compounds on AMS targets. The expression of genes in the network was analyzed in an IS dataset to identify common key targets of Ginkgo biloba active compounds for both AMS and IS prevention.

Results

The intersection between the targets of Ginkgo biloba active compounds and AMS-related genes identified 43 overlapping genes. Analysis of the protein–protein interaction network showed that VEGFA, TP53, SERPINE1, and PTGS2 were among the key hub genes. Analysis of the IS dataset identified significant differences in the expression levels of CAT, TP53, CXCL8, NFKBIA, and PTGS2. These genes were used to construct a visual nomogram prediction model for IS prognosis with promising clinical implications. Molecular docking and molecular dynamics simulations indicated that sesamin stably targeted and bound to PTGS2.

Conclusions

Active ingredients of Ginkgo biloba, including luteolin, quercetin, and sesamin, have the potential to modulate the development of AMS and IS through targeted interactions with key proteins, including TP53, CXCL8, NFKBIA, PTGS2, and CAT.

背景 采用分子对接、分子动力学模拟和中药网络药理学相结合的方法,研究银杏叶活性化合物对急性山地病(AMS)和缺血性中风(IS)预防作用的共同关键靶点和潜在机制。 材料与方法 利用中药系统药理学数据库和分析平台筛选银杏叶的主要活性化合物及其相应靶点。我们通过挖掘多个数据库获得 AMS 相关基因,并将这些基因与银杏叶的主要活性化合物进行交叉关联,以确定治疗 AMS 的相关作用靶点。我们利用 STRING 数据库构建了银杏叶活性化合物对 AMS 靶点影响的蛋白质-蛋白质相互作用网络。在 IS 数据集中分析了网络中基因的表达,以确定银杏叶活性化合物在预防 AMS 和 IS 方面的共同关键靶点。 结果 银杏叶活性化合物的靶点与 AMS 相关基因之间的交叉发现了 43 个重叠基因。蛋白相互作用网络分析显示,VEGFA、TP53、SERPINE1 和 PTGS2 是关键的枢纽基因。对 IS 数据集的分析发现,CAT、TP53、CXCL8、NFKBIA 和 PTGS2 的表达水平存在显著差异。这些基因被用于构建IS预后的可视化提名图预测模型,具有良好的临床意义。分子对接和分子动力学模拟表明,芝麻素能稳定地靶向结合 PTGS2。 结论 银杏叶的活性成分,包括木犀草素、槲皮素和芝麻素,有可能通过与 TP53、CXCL8、NFKBIA、PTGS2 和 CAT 等关键蛋白的靶向相互作用,调节 AMS 和 IS 的发展。
{"title":"Ginkgo biloba active compounds can modulate the development of acute mountain sickness and ischemic stroke as discovered by network pharmacology and molecular docking","authors":"Haoran Guo,&nbsp;Xueran Kang,&nbsp;Ying Xu,&nbsp;Chengbin Wang,&nbsp;Chi Wang","doi":"10.1002/ila2.58","DOIUrl":"https://doi.org/10.1002/ila2.58","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>A combination of molecular docking, molecular dynamics simulations, and herbal network pharmacology was used to investigate the shared key targets and potential mechanisms underlying the preventive effects of <i>Ginkgo biloba</i> active compounds against acute mountain sickness (AMS) and ischemic stroke (IS).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Material and Methods</h3>\u0000 \u0000 <p>The Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform was used to screen the main active compounds of <i>Ginkgo biloba</i> and their corresponding targets. We obtained AMS-related genes by mining several databases and cross-correlated them with key active compounds of <i>Ginkgo biloba</i> to identify relevant action targets for treating AMS. The STRING database was used to construct a protein–protein interaction network of the effect of <i>Ginkgo biloba</i> active compounds on AMS targets. The expression of genes in the network was analyzed in an IS dataset to identify common key targets of <i>Ginkgo biloba</i> active compounds for both AMS and IS prevention.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The intersection between the targets of <i>Ginkgo biloba</i> active compounds and AMS-related genes identified 43 overlapping genes. Analysis of the protein–protein interaction network showed that <i>VEGFA</i>, <i>TP53</i>, <i>SERPINE1</i>, and <i>PTGS2</i> were among the key hub genes. Analysis of the IS dataset identified significant differences in the expression levels of <i>CAT</i>, <i>TP53</i>, <i>CXCL8</i>, <i>NFKBIA</i>, and <i>PTGS2</i>. These genes were used to construct a visual nomogram prediction model for IS prognosis with promising clinical implications. Molecular docking and molecular dynamics simulations indicated that sesamin stably targeted and bound to PTGS2.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Active ingredients of <i>Ginkgo biloba</i>, including luteolin, quercetin, and sesamin, have the potential to modulate the development of AMS and IS through targeted interactions with key proteins, including TP53, CXCL8, NFKBIA, PTGS2, and CAT.</p>\u0000 </section>\u0000 </div>","PeriodicalId":100656,"journal":{"name":"iLABMED","volume":"2 3","pages":"178-196"},"PeriodicalIF":0.0,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ila2.58","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142404313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical efficacy and computed tomography diagnostic value of bedaquiline-containing regimens in the treatment of drug-resistant pulmonary tuberculosis 含贝达喹啉方案治疗耐药肺结核的临床疗效和计算机断层扫描诊断价值
Pub Date : 2024-08-27 DOI: 10.1002/ila2.57
Saiduo Liu, Xinchun Ye, Fang Cheng, Kaijia Wu, Jiandan Yu, Hongye Ning, Jichan Shi, Hongzhou Lu, Wei Chen

Objective

This study investigated the clinical efficacy of bedaquiline-containing regimens in the treatment of drug-resistant pulmonary tuberculosis and the diagnostic value of computed tomography (CT).

Methods

We retrospectively analyzed the clinical diagnosis, treatment, and CT imaging data of patients with drug-resistant pulmonary tuberculosis treated in Wenzhou Central Hospital from 1 January to 31 December 2022. According to whether the treatment regimen contained bedaquiline, the patients were divided into an observation group (bedaquiline tablets + background regimen) and a control group (background regimen). The clinical efficacy and pulmonary CT changes before and after treatment were analyzed in both groups.

Results

After 24 weeks of treatment, there was no statistically significant difference in the white blood cell count or concentrations of hemoglobin, alanine aminotransferase, serum albumin, or creatinine between the two groups (t = 0.71, 0.93, 0.05, 0.18, and 0.08, respectively; p > 0.05). After 4, 8, and 12 weeks of treatment, there was no statistically significant difference in the sputum culture-negative conversion rate between the two groups (χ2 = 2.67, 0.48, and 1.82, respectively; p > 0.05). At 24 weeks of treatment, the sputum culture-negative conversion rate in the observation group reached 100%, which was significantly higher than that in the control group (χ2 = 3.97, p < 0.05). The effective absorption rates on chest imaging in the two groups of patients at 12 weeks were 83.33% and 57.89%, respectively. At 24 weeks of treatment, the effective absorption rates were 88.00% and 65.85% in the two groups, with a statistically significant difference (χ2 = 3.98; p < 0.05). There were significant differences in cavity absorption at 24 weeks (χ2 = 4.33, p < 0.05) and 48 weeks after treatment (χ2 = 10.63, p < 0.05).

Conclusion

The addition of bedaquiline to the background regimen improved the sputum culture-negative conversion rate and chest imaging effective rate. Patients achieved good results at the end of the 24-week treatment period.

目的 本研究探讨了含贝达喹啉方案治疗耐药肺结核的临床疗效及计算机断层扫描(CT)的诊断价值。 方法 回顾性分析温州市中心医院2022年1月1日至12月31日收治的耐药肺结核患者的临床诊断、治疗和CT影像学资料。根据治疗方案中是否含有贝达喹啉,将患者分为观察组(贝达喹啉片+背景方案)和对照组(背景方案)。分析两组患者治疗前后的临床疗效和肺部 CT 变化。 结果 治疗 24 周后,两组的白细胞计数和血红蛋白、丙氨酸氨基转移酶、血清白蛋白或肌酐浓度差异无统计学意义(t = 0.71、0.93、0.05、0.18 和 0.08,分别为 p >0.05)。治疗 4 周、8 周和 12 周后,两组痰培养阴转率差异无统计学意义(χ2 分别为 2.67、0.48 和 1.82;P >;0.05)。治疗24周时,观察组痰培养阴转率达到100%,明显高于对照组(χ2 = 3.97,P <0.05)。治疗 12 周时,两组患者胸部造影的有效吸收率分别为 83.33% 和 57.89%。治疗 24 周时,两组患者的有效吸收率分别为 88.00% 和 65.85%,差异有统计学意义(χ2 = 3.98; p <0.05)。治疗后 24 周(χ2 = 4.33,p < 0.05)和 48 周(χ2 = 10.63,p < 0.05)的空穴吸收率存在明显差异。 结论 在背景方案中加入贝达喹啉可提高痰培养阴转率和胸部影像学有效率。在 24 周的治疗期结束时,患者取得了良好的疗效。
{"title":"Clinical efficacy and computed tomography diagnostic value of bedaquiline-containing regimens in the treatment of drug-resistant pulmonary tuberculosis","authors":"Saiduo Liu,&nbsp;Xinchun Ye,&nbsp;Fang Cheng,&nbsp;Kaijia Wu,&nbsp;Jiandan Yu,&nbsp;Hongye Ning,&nbsp;Jichan Shi,&nbsp;Hongzhou Lu,&nbsp;Wei Chen","doi":"10.1002/ila2.57","DOIUrl":"https://doi.org/10.1002/ila2.57","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>This study investigated the clinical efficacy of bedaquiline-containing regimens in the treatment of drug-resistant pulmonary tuberculosis and the diagnostic value of computed tomography (CT).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We retrospectively analyzed the clinical diagnosis, treatment, and CT imaging data of patients with drug-resistant pulmonary tuberculosis treated in Wenzhou Central Hospital from 1 January to 31 December 2022. According to whether the treatment regimen contained bedaquiline, the patients were divided into an observation group (bedaquiline tablets + background regimen) and a control group (background regimen). The clinical efficacy and pulmonary CT changes before and after treatment were analyzed in both groups.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>After 24 weeks of treatment, there was no statistically significant difference in the white blood cell count or concentrations of hemoglobin, alanine aminotransferase, serum albumin, or creatinine between the two groups (<i>t</i> = 0.71, 0.93, 0.05, 0.18, and 0.08, respectively; <i>p</i> &gt; 0.05). After 4, 8, and 12 weeks of treatment, there was no statistically significant difference in the sputum culture-negative conversion rate between the two groups (<i>χ</i><sup>2</sup> = 2.67, 0.48, and 1.82, respectively; <i>p</i> &gt; 0.05). At 24 weeks of treatment, the sputum culture-negative conversion rate in the observation group reached 100%, which was significantly higher than that in the control group (<i>χ</i><sup>2</sup> = 3.97, <i>p</i> &lt; 0.05). The effective absorption rates on chest imaging in the two groups of patients at 12 weeks were 83.33% and 57.89%, respectively. At 24 weeks of treatment, the effective absorption rates were 88.00% and 65.85% in the two groups, with a statistically significant difference (<i>χ</i><sup>2</sup> = 3.98; <i>p</i> &lt; 0.05). There were significant differences in cavity absorption at 24 weeks (<i>χ</i><sup>2</sup> = 4.33, <i>p</i> &lt; 0.05) and 48 weeks after treatment (<i>χ</i><sup>2</sup> = 10.63, <i>p</i> &lt; 0.05).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The addition of bedaquiline to the background regimen improved the sputum culture-negative conversion rate and chest imaging effective rate. Patients achieved good results at the end of the 24-week treatment period.</p>\u0000 </section>\u0000 </div>","PeriodicalId":100656,"journal":{"name":"iLABMED","volume":"2 3","pages":"149-156"},"PeriodicalIF":0.0,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ila2.57","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142404862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinicopathological and prognostic role of CEP55 expression in cancer patients: A meta-analysis of 31 studies with 12,543 patients CEP55表达在癌症患者中的临床病理和预后作用:对31项研究12,543例患者的荟萃分析
Pub Date : 2024-08-19 DOI: 10.1002/ila2.50
Jiangguo Zhang, Xiaoyin Zhang

Background

Dysregulated expression of centrosomal protein 55 (CEP55) has been detected in multiple types of cancers. However, the clinical value of CEP55 expression in cancer is controversial. The current meta-analysis quantitatively investigated the association between CEP55 expression and prognostic outcomes in cancers.

Methods

A literature search was performed using the Chinese National Knowledge Infrastructure (CNKI), Wanfang databases, Web of Science, Embase, MEDLINE, PubMed, and Cochrane Library for primary studies. The pooled hazard ratios (HRs) and odds ratios (ORs) were used to investigate the association between CEP55 expression and its prognostic and clinicopathological value in cancers.

Results

A total of 12,543 patients from 31 studies were included in this meta-analysis. High CEP55 expression was significantly associated with poor differentiation, deeper tumor invasion and increased lymph node metastasis in cancer patients. The pooled results indicated that elevated CEP55 expression can predict a poor overall survival (OS) and disease-free survival (DFS) in cancers. These results should be interpreted with caution because of publication bias. However, the pooled HR for OS of lung cancers was 1.50 (95% CI = 1.36–1.67, p < 0.01) with no heterogeneity and publication bias.

Conclusions

CEP55 overexpression correlated with poor cancer differentiation, deeper tumor invasion, and increased lymph node metastasis, suggesting that CEP55 may serve as a predictive and prognostic biomarker for cancers, especially for lung cancers.

中心体蛋白55 (CEP55)表达异常已在多种类型的癌症中被检测到。然而,CEP55在癌症中表达的临床价值存在争议。目前的荟萃分析定量研究了CEP55表达与癌症预后结果之间的关系。方法采用中国知网(CNKI)、万方数据库、Web of Science、Embase、MEDLINE、PubMed、Cochrane Library进行文献检索,进行初步研究。采用合并风险比(hr)和优势比(ORs)研究CEP55表达与肿瘤预后和临床病理价值之间的关系。结果来自31项研究的12,543例患者被纳入本荟萃分析。CEP55高表达与肿瘤患者分化差、肿瘤侵袭更深、淋巴结转移增加显著相关。综合结果表明,CEP55表达升高可以预测癌症患者较差的总生存期(OS)和无病生存期(DFS)。由于存在发表偏倚,这些结果应谨慎解读。然而,肺癌OS的总HR为1.50 (95% CI = 1.36-1.67, p <;0.01),无异质性和发表偏倚。结论CEP55过表达与肿瘤分化差、肿瘤侵袭更深、淋巴结转移增加相关,提示CEP55可能是癌症,特别是肺癌的预测和预后生物标志物。
{"title":"Clinicopathological and prognostic role of CEP55 expression in cancer patients: A meta-analysis of 31 studies with 12,543 patients","authors":"Jiangguo Zhang,&nbsp;Xiaoyin Zhang","doi":"10.1002/ila2.50","DOIUrl":"https://doi.org/10.1002/ila2.50","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Dysregulated expression of centrosomal protein 55 (CEP55) has been detected in multiple types of cancers. However, the clinical value of CEP55 expression in cancer is controversial. The current meta-analysis quantitatively investigated the association between CEP55 expression and prognostic outcomes in cancers.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A literature search was performed using the Chinese National Knowledge Infrastructure (CNKI), Wanfang databases, Web of Science, Embase, MEDLINE, PubMed, and Cochrane Library for primary studies. The pooled hazard ratios (HRs) and odds ratios (ORs) were used to investigate the association between CEP55 expression and its prognostic and clinicopathological value in cancers.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 12,543 patients from 31 studies were included in this meta-analysis. High CEP55 expression was significantly associated with poor differentiation, deeper tumor invasion and increased lymph node metastasis in cancer patients. The pooled results indicated that elevated CEP55 expression can predict a poor overall survival (OS) and disease-free survival (DFS) in cancers. These results should be interpreted with caution because of publication bias. However, the pooled HR for OS of lung cancers was 1.50 (95% <i>CI</i> = 1.36–1.67, <i>p</i> &lt; 0.01) with no heterogeneity and publication bias.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>CEP55 overexpression correlated with poor cancer differentiation, deeper tumor invasion, and increased lymph node metastasis, suggesting that CEP55 may serve as a predictive and prognostic biomarker for cancers, especially for lung cancers.</p>\u0000 </section>\u0000 </div>","PeriodicalId":100656,"journal":{"name":"iLABMED","volume":"2 4","pages":"327-340"},"PeriodicalIF":0.0,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ila2.50","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143252791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
iLABMED
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1